Literature DB >> 20609857

Danger signs in drug hypersensitivity.

Kathrin Scherer1, Andreas J Bircher.   

Abstract

ADRs are frequently considered iatrogenic complications and, therefore, pose a specific challenge for the physician-patient relationship. Early recognition of a potential ADR is possible, especially on the skin, in addition to characteristic clinical danger signs. Cutaneous manifestations are variable, depending on the causative pathomechanism. It is impossible to conclude the causative agent from the morphology of the cutaneous lesions. The intake of several drugs in the time before the elicitation of the drug reaction usually poses a diagnostic challenge. It is crucial for the precision of any further allergological work-up to document the type of rash precisely as well as the time course of drug intake and appearance of the first symptoms. involvement of internal organs or circulating blood cells. Timely recognition of such cutaneous lesions and the correct differential diagnosis with prompt withdrawal of the putative culprit drug are essential to reducing morbidity and preventing mortality. This article discusses risk factors, early symptoms, and danger signs indicating a possibly severe course of an ADR and advises on early actions. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609857     DOI: 10.1016/j.mcna.2010.04.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

1.  Rejuvenating activity of salidroside (SDS): dietary intake of SDS enhances the immune response of aged rats.

Authors:  Linlin Lu; Jiangshui Yuan; Shicui Zhang
Journal:  Age (Dordr)       Date:  2012-02-26

2.  Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population.

Authors:  Stephanie Albin; Shradha Agarwal
Journal:  Allergy Asthma Proc       Date:  2014 Nov-Dec       Impact factor: 2.587

3.  Dietary intake of resveratrol enhances the adaptive immunity of aged rats.

Authors:  Jiangshui Yuan; Linlin Lu; Zongliang Zhang; Shicui Zhang
Journal:  Rejuvenation Res       Date:  2012-10       Impact factor: 4.663

4.  Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing.

Authors:  Philipp Schrüfer; Johanna Stoevesandt; Axel Trautmann
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-22       Impact factor: 3.406

5.  Knowledge, attitudes, and practices survey of drug allergy among healthcare practitioners in central China: a multicenter study.

Authors:  Yin Wang; Rongfei Zhu; Nan Huang; Wenjing Li; Lin Yang; Shucheng Zhang; Guanghui Liu
Journal:  Asia Pac Allergy       Date:  2016-04-28

Review 6.  An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.

Authors:  I Doña; J C Caubet; K Brockow; M Doyle; E Moreno; I Terreehorst; M J Torres
Journal:  Clin Transl Allergy       Date:  2018-05-10       Impact factor: 5.871

7.  Maculopapular Exanthema After the Second Dose of Evolocumab.

Authors:  Victoria Ghernautan; Masoud Amini; Issac Sachmechi
Journal:  Cureus       Date:  2021-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.